Skip to content
2000
Volume 6, Issue 2
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

The Royal Thai College of Obstetricians and Gynaecologists (RTCOG) clinical practice guideline (CPG) does not recommend against elective Cesarean Section (CS) in case of prenatal maternal COVID-19 infections without obstetric indication. In Thailand, little is known about the mode of deliveries and perinatal outcomes in the mentioned group of patients. Therefore, this study aims to fill the gap in knowledge.

Objective

The objective of this study was to compare the mode of deliveries and perinatal outcomes between pregnant women, who were infected with COVID-19 and those who were without COVID-19 infection.

Methods

The retrospective cohort study was based on data retrieved between February 1st and March 31st, 2023. The primary data was collected between July 1st, 2021, and October 31st, 2022. Women with COVID-19 infection were matched with the non-COVID-19 group in a 1:1 ratio by date at antenatal care (± 7 days) and their gestational age (± 1 week). Comparison of maternal and perinatal outcomes was made by using chi-squared, Fisher’s exact, relative risk, and t-test as appropriate in STATA software version 10.0.

Results

A total of 252 participants were recruited in this study, with 126 patients in each group. Demographic data between the two groups were comparable except for previous CS. The CS rates in the COVID-19 and non-COVID-19 groups were 46.03% and 30.95%, respectively, with = 0.009. The significantly increased relative risk of CS in COVID-19 was 1.49 (95%CI, 1.07 to 2.05, = 0.02). Eight women out of 126 had undergone CS with a “COVID-19 infection” indication ( = 0.007). The length of the maternal hospital stay was comparable. No serious maternal complications were observed. Perinatal outcomes were similar among the two groups, except for neonatal jaundice ( = 0.029), with no reports of COVID-19 infections in delivery-related personnel.

Conclusion

Prenatal COVID-19 infections lead to an increase in CS rate, while perinatal morbidities were comparable in both groups, with COVID-19 and non-COVID-19. The RTCOG’s CPG should be modified.

Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975291928240319083013
2024-03-26
2025-10-03
Loading full text...

Full text loading...

References

  1. TaylorL. COVID-19: True global death toll from pandemic is almost 15 million, says WHO.BMJ2022377o114410.1136/bmj.o1144 35523437
    [Google Scholar]
  2. Thai Department of Disease Control (TDDC). Special announcement of COVID-19 on 29 February 2020. The corona virus 2019 news release.2023Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/news/news_no35_290263_1.pdf (Accessed on: 1st September, 2023).
  3. SuphanchaimatR. TeekasapP. NittayasootN. PhaiyaromM. CetthakrikulN. Forecasted trends of the new COVID-19 epidemic due to the omicron variant in Thailand, 2022.Vaccines2022107102410.3390/vaccines10071024 35891188
    [Google Scholar]
  4. RajgorD.D. LeeM.H. ArchuletaS. BagdasarianN. QuekS.C. The many estimates of the COVID-19 case fatality rate.Lancet Infect. Dis.202020777677710.1016/S1473‑3099(20)30244‑9 32224313
    [Google Scholar]
  5. Thai Ministry of Public Health (TMOPH). Six dangers of COVID- 19 infection in pregnancy published on 31st August, 2020.2023 Available from: https://multimedia.anamai.moph.go.th/infographics/info298_COVID19.
  6. BrendolinM. FullerT. WakimotoM. Severe maternal morbidity and mortality during the COVID-19 pandemic: A cohort study in Rio de Janeiro.IJID Reg.202361610.1016/j.ijregi.2022.11.004 36407853
    [Google Scholar]
  7. SinghN. RaiS.N. SinghV. SinghM.P. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19.J. Chem. Neuroanat.202011010187410.1016/j.jchemneu.2020.101874 33091590
    [Google Scholar]
  8. WuW. JiaoX. SongW. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC.Front. Endocrinol.202314118788210.3389/fendo.2023.1187882 37347115
    [Google Scholar]
  9. PatelP. KulkarniS. GuerreroM. PersaudC. ZuberiJ. RebeinB. Emergency cesarean section at 38 weeks of gestation with COVID-19 pneumonia: A case report.Am. J. Case Rep.202021e926591 33339814
    [Google Scholar]
  10. FerrazziE. FrigerioL. SavasiV. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: A retrospective analysis.BJOG202012791116112110.1111/1471‑0528.16278 32339382
    [Google Scholar]
  11. The Royal Thai College of Obstetricians and Gynaecologists (RTCOG). Clinical practice guideline management of COVID-19 infection in pregnancy (20th March, 2020).2023Available from: https://covid19.dms.go.th/backend///Content/Content_File/Covid_Health/Attach/25630324214133PM_CPG-Covid-Preg-20Mar20.pdf (Accessed on: 1st September, 2023).
  12. SunuwarN. JaishiP.P. TwayanaA.R. NeupaneP.K. NeupaneS.K. A retrospective study of COVID during pregnancy and the outcome of vaginal delivery.Ann. Med. Surg.20228410488010.1016/j.amsu.2022.104880 36438876
    [Google Scholar]
  13. CaiJ. TangM. GaoY. Cesarean section or vaginal delivery to prevent possible vertical transmission from a pregnant mother confirmed with COVID-19 to a neonate: A systematic review.Front. Med.2021863494910.3389/fmed.2021.634949 33681259
    [Google Scholar]
  14. GuptaP. KumarS. SharmaS.S. SARS‐CoV‐2 prevalence and maternal‐perinatal outcomes among pregnant women admitted for delivery: Experience from COVID‐19‐dedicated maternity hospital in Jammu, Jammu and Kashmir (India).J. Med. Virol.20219395505551410.1002/jmv.27074 33974301
    [Google Scholar]
  15. GuptaV. YadavY. SharmaR. MishraM. AmbedkarD. GuptaV. Maternal and perinatal outcomes of hospitalized COVID-19 positive pregnant women.Cureus2022142e2181710.7759/cureus.21817 35261836
    [Google Scholar]
  16. ChinnJ. SedighimS. KirbyK.A. Characteristics and outcomes of women with COVID-19 giving birth at US academic centers during the COVID-19 pandemic.JAMA Netw. Open202148e212045610.1001/jamanetworkopen.2021.20456 34379123
    [Google Scholar]
  17. MullinsE. EvansD. VinerR.M. O’BrienP. MorrisE. Coronavirus in pregnancy and delivery: Rapid review.Ultrasound Obstet. Gynecol.202055558659210.1002/uog.22014 32180292
    [Google Scholar]
  18. PhupongV. Coronavirus disease-19 and pregnancy.Thai J Obstet Gynaecol20202826670
    [Google Scholar]
  19. SmithV. SeoD. WartyR. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.PLoS One2020156e023418710.1371/journal.pone.0234187 32497090
    [Google Scholar]
  20. AkhtarH. PatelC. AbuelgasimE. HarkyA. COVID-19 (SARS-CoV-2) infection in pregnancy: A systematic review.Gynecol. Obstet. Invest.202085429530610.1159/000509290 32728006
    [Google Scholar]
  21. MeloG.C. AraújoK.C.G.M. COVID-19 infection in pregnant women, preterm delivery, birth weight, and vertical transmission: A systematic review and meta-analysis.Cad. Saude Publica2020367e0008732010.1590/0102‑311x00087320 32696830
    [Google Scholar]
  22. NovoaR.H. QuintanaW. LlancaríP. Urbina-QuispeK. Guevara-RíosE. VenturaW. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review.Travel Med. Infect. Dis.20213910191910.1016/j.tmaid.2020.101919 33220455
    [Google Scholar]
  23. JuanJ. GilM.M. RongZ. ZhangY. YangH. PoonL.C. Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: Systematic review.Ultrasound Obstet. Gynecol.2020561152710.1002/uog.22088 32430957
    [Google Scholar]
  24. DubeyP. ReddyS.Y. ManuelS. DwivediA.K. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis.Eur. J. Obstet. Gynecol. Reprod. Biol.202025249050110.1016/j.ejogrb.2020.07.034 32795828
    [Google Scholar]
  25. YangZ. WangM. ZhuZ. LiuY. Coronavirus disease 2019 (COVID-19) and pregnancy: A systematic review.J. Matern. Fetal Neonatal Med.20223581619162210.1080/14767058.2020.1759541 32354293
    [Google Scholar]
  26. JafariM. PormohammadA. NeshinS.S.A. Clinical characteristics and outcomes of pregnant women with COVID‐19 and comparison with control patients: A systematic review and meta‐analysis.Rev. Med. Virol.202131511610.1002/rmv.2208 33387448
    [Google Scholar]
  27. WeiS.Q. BertrandB.M. LiuS. AugerN. The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis.CMAJ202119316E540E54810.1503/cmaj.202604 33741725
    [Google Scholar]
  28. MarchandG. PatilA.S. MasoudA.T. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021.AJOG Glob. Rep.20222110004910.1016/j.xagr.2021.100049 35005663
    [Google Scholar]
  29. ChmielewskaB. BarrattI. TownsendR. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: A systematic review and meta-analysis.Lancet Glob. Health202196e759e77210.1016/S2214‑109X(21)00079‑6 33811827
    [Google Scholar]
  30. PattanachairujW. SrisatapornT. SangkomkamhangU. TangsiriwatthanaT. Pregnancy outcomes among singleton pregnant women with coronavirus disease 2019 infection: A single-center study in Thailand.Thai J Obstet Gynaecol2023316409420
    [Google Scholar]
  31. GiulianiF. DeantoniS. PapageorghiouA.T. Vaginal vs cesarean delivery for COVID-19 in pregnancy.Am. J. Obstet. Gynecol.2023228335835910.1016/j.ajog.2022.10.020 36288753
    [Google Scholar]
/content/journals/covid/10.2174/0126667975291928240319083013
Loading
/content/journals/covid/10.2174/0126667975291928240319083013
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test